Skip to main content

The Wistar Institute

|

Groundbreaking of Life Science Building Encapsulates West Philadelphia Growth and Power of Partnership 

University Place Associates (UPA) celebrated the groundbreaking of soon-to-be-constructed 3.0 University Place, a more than 250,000 square foot, technologically advanced and environmentally sustainable life science building in West Philadelphia th…
|

Wistar and Peter Mac Scientists Discover Fundamental Mechanism That Fine-tunes Gene Expression and Is Disrupted in Cancer

PHILADELPHIA and MELBOURNE, Australia — (May. 17, 2021) — A team of scientists from The Wistar Institute in Philadelphia and the Peter MacCallum Cancer Center in Melbourne, Australia, discovered a new checkpoint mechanism that fine-tunes gene tran…
|

The Wistar Institute Receives Transformative National Science Foundation Grant to Expand and Accelerate STEM Training Program

PHILADELPHIA — (May 11, 2021) — The Wistar Institute received a $599,969 grant from the National Science Foundation (NSF) to scale up its Biomedical Technician Training (BTT) Program to train more students in a condensed timeline with a direct pat…
|

Wistar Expands International Training of the Next Generation of Scientists With the University of Bologna

PHILADELPHIA — (April 27, 2021) — The Wistar Institute and the University of Bologna (Unibo) in Italy have established the Wistar-Unibo Ph.D. Exchange Program in Cell and Molecular Biology to bring Unibo graduate students to Wistar for their three…
|

Latest Wistar Discoveries: Fine-tuning Vaccine Delivery in Preclinical Models to Advance MERS DNA Vaccine Candidate and Discovering New Targets for Cancer Therapy

A team of Wistar scientists led by Dr. David Weiner, Wistar executive vice president, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Professor in Cancer Research, and Dr. Ami P…
|

Wistar and Leiden University Medical Center Engage in Collaborative Seminars

Two institutions forge a valuable international collaboration based on training and emerging research alignment. Wistar and Leiden University Medical Center (LUMC) in the Netherlands have started building a scientific bridge by connecting virtuall…
|

Dr. Ebony Gary Received Awards from American Association of Immunologists and American Society of Gene & Cell Therapy

Congratulations to Ebony Gary, Ph.D., postdoctoral fellow from the Weiner lab, for receiving the 2021 AAI Trainee Abstract Award from the American Association of Immunology and having her abstract selected for presentation at Virtual Imm…
|

Low-dose Administration of MERS DNA Vaccine Candidate Induces Potent Immunity and Protects From Virus Challenge in Preclinical Models

PHILADELPHIA — (April 22, 2021) — A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate…
|

Wistar Scientists Discover New Mechanism Through Which Senescent Cells Turn On Genes That Encode for Secreted Tumor-regulating Factors

PHILADELPHIA — (April 1, 2021) — Scientists at The Wistar Institute identified a new mechanism of transcriptional control of cellular senescence that drives the release of inflammatory molecules that influence tumor development through altering th…
|

Richard M. Horowitz Appointed Chair of The Wistar Institute’s Board of Trustees

PHILADELPHIA — (March 23, 2021) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to announce the appointment of Richard M. Horowitz as chair of its Board of Trustees. Horowitz,…